Short Interest in Polyrizon Ltd. (NASDAQ:PLRZ) Declines By 47.2%

Polyrizon Ltd. (NASDAQ:PLRZ) was the target of a significant decline in short interest in the month of April. As of April 30th, there was short interest totaling 35,463 shares, a decline of 47.2% from the April 15th total of 67,203 shares. Currently, 1.9% of the shares of the company are sold short. Based on an average trading volume of 70,232 shares, the short-interest ratio is currently 0.5 days.

Wall Street Analysts Forecast Growth

PLRZ has been the topic of several research reports. Wall Street Zen raised shares of Polyrizon from a “sell” rating to a “hold” rating in a research report on Saturday, May 2nd. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Polyrizon in a research report on Monday, May 4th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has a consensus rating of “Sell”.

Polyrizon Stock Performance

Shares of NASDAQ PLRZ traded down $0.22 during midday trading on Friday, hitting $14.80. The company’s stock had a trading volume of 27,517 shares, compared to its average volume of 60,116. The stock has a fifty day moving average price of $13.49 and a 200 day moving average price of $11.42. Polyrizon has a one year low of $2.88 and a one year high of $18.20.

Polyrizon (NASDAQ:PLRZ) last posted its quarterly earnings results on Saturday, February 14th. The company reported ($2.81) earnings per share (EPS) for the quarter.

Institutional Trading of Polyrizon

A hedge fund recently bought a new stake in Polyrizon stock. Jane Street Group LLC purchased a new stake in Polyrizon Ltd. (NASDAQ:PLRZ) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 14,032 shares of the company’s stock, valued at approximately $119,000. Jane Street Group LLC owned 1.35% of Polyrizon as of its most recent SEC filing.

About Polyrizon

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.